120 related articles for article (PubMed ID: 10628328)
1. Electronic structure and cytotoxic activity of "half-mustard type" phenothiazines by MM3 and PM3 methods.
Kurihara T; Nojima K; Sakagami H; Motohashi N; Molnár J
Anticancer Res; 1999; 19(5B):3895-9. PubMed ID: 10628328
[TBL] [Abstract][Full Text] [Related]
2. Chemical structure and tumor type specificity of "half-mustard type" phenothiazines.
Motohashi N; Kurihara T; Sakagami H; Szabo D; Csuri K; Molnár J
Anticancer Res; 1999; 19(3A):1859-64. PubMed ID: 10470128
[TBL] [Abstract][Full Text] [Related]
3. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
[TBL] [Abstract][Full Text] [Related]
4. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
5. Relationship between cytotoxic activity and dipole moment for phthalimido- and chloroethyl-phenothiazines.
Kurihara T; Motohashi N; Sakagami H; Molnár J
Anticancer Res; 1999; 19(5B):4081-3. PubMed ID: 10628357
[TBL] [Abstract][Full Text] [Related]
6. Correlation between structure and diverse biological activities of "half-mustard type" phenothiazines.
Motohashi N; Kurihara T; Satoh K; Sakagami H; Molnár J
Anticancer Res; 1997; 17(6D):4403-6. PubMed ID: 9494541
[TBL] [Abstract][Full Text] [Related]
7. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
[TBL] [Abstract][Full Text] [Related]
8. The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
Hu K; Yao X
Phytother Res; 2003 Jun; 17(6):620-6. PubMed ID: 12820229
[TBL] [Abstract][Full Text] [Related]
9. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
10. Radical intensity and differentiation-inducing activity of benzo[a]phenothiazines and phenothiazines.
Satoh K; Sakagami H; Kurihara T; Motohashi N
Anticancer Res; 1997; 17(4A):2465-9. PubMed ID: 9252664
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines.
Molnar J; Mandi Y; Petri I; Petofi S; Sakagami H; Kurihara T; Motohashi N
Anticancer Res; 1993; 13(2):439-42. PubMed ID: 8517660
[TBL] [Abstract][Full Text] [Related]
12. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
[TBL] [Abstract][Full Text] [Related]
13. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
14. Relationship between biological activity and dipole moment in benzo[a]phenothiazines.
Motohashi N; Kurihara T; Yamanaka W; Satoh K; Sakagami H; Molnár J
Anticancer Res; 1997; 17(5A):3431-5. PubMed ID: 9413182
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
16. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
17. Is coulomb explosion a damaging mechanism for (125)IUdR?
Pomplun E; Sutmann G
Int J Radiat Biol; 2004; 80(11-12):855-60. PubMed ID: 15764393
[TBL] [Abstract][Full Text] [Related]
18. Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents.
Mosnaim AD; Ranade VV; Wolf ME; Puente J; Antonieta Valenzuela M
Am J Ther; 2006; 13(3):261-73. PubMed ID: 16772768
[TBL] [Abstract][Full Text] [Related]
19. Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank.
Pluta K; Jeleń M; Morak-Młodawska B; Zimecki M; Artym J; Kocieba M
Pharmacol Rep; 2010; 62(2):319-32. PubMed ID: 20508288
[TBL] [Abstract][Full Text] [Related]
20. Relationship between pi-electron distribution and anticancer activity of benzo[a]phenothiazines.
Motohashi N; Sasaki Y; Wakabayashi Y; Sakagami H; Molnar J; Kurihara T
Anticancer Res; 1992; 12(5):1423-6. PubMed ID: 1444201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
